MAIA Biotechnology, Inc.(NYSE Amex Equities : MAIA)
MAIA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|VRTX||Vertex Pharmaceuticals, Inc.||1.66%||298.83||1.9%||$438.24m|
|GILD||Gilead Sciences, Inc.||0.65%||62.00||1.0%||$379.78m|
|REGN||Regeneron Pharmaceuticals, Inc.||-1.35%||622.15||2.6%||$351.29m|
|SNSS||Sunesis Pharmaceuticals, Inc.||-12.15%||3.47||0.7%||$242.57m|
|GOVX||GeoVax Labs, Inc.||-0.35%||2.86||0.0%||$145.88m|
|CRSP||CRISPR Therapeutics AG||-7.69%||75.13||0.6%||$117.81m|
|PLRX||Pliant Therapeutics, Inc.||11.19%||21.16||0.0%||$108.38m|
|RYTM||Rhythm Pharmaceuticals, Inc.||7.19%||22.65||0.0%||$105.42m|
|BMRN||BioMarin Pharmaceutical, Inc.||0.00%||95.70||4.2%||$98.26m|
MAIA Biotechnology, Inc. is a clinical stage biotechnology company that is engaged in the discovery, development and commercialization of therapies targeting cancer. The company?s lead product THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded on 3rd August, 2018 and is headquartered in Chicago.